WallStSmart

Chime Financial, Inc. Class A Common Stock (CHYM)vsSAP SE ADR (SAP)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

SAP SE ADR generates 1583% more annual revenue ($36.80B vs $2.19B). SAP leads profitability with a 19.5% profit margin vs -46.2%. SAP earns a higher WallStSmart Score of 58/100 (C).

CHYM

Avoid

35

out of 100

Grade: F

Growth: 6.7Profit: 3.0Value: 5.0Quality: 6.5
Piotroski: 3/9Altman Z: -1.15

SAP

Buy

58

out of 100

Grade: C

Growth: 5.3Profit: 8.5Value: 7.3Quality: 8.0
Piotroski: 6/9Altman Z: 3.09
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for CHYM.

SAPSignificantly Overvalued (-88.8%)

Margin of Safety

-88.8%

Fair Value

$104.04

Current Price

$168.95

$64.91 premium

UndervaluedFair: $104.04Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CHYM2 strengths · Avg: 9.0/10
Debt/EquityHealth
0.1010/10

Conservative balance sheet, low leverage

Revenue GrowthGrowth
25.5%8/10

Revenue surging 25.5% year-over-year

SAP6 strengths · Avg: 8.8/10
Market CapQuality
$217.55B10/10

Mega-cap, among the largest globally

Altman Z-ScoreHealth
3.0910/10

Safe zone — low bankruptcy risk

Debt/EquityHealth
0.189/10

Conservative balance sheet, low leverage

PEG RatioValuation
0.798/10

Growing faster than its price suggests

Operating MarginProfitability
29.2%8/10

Strong operational efficiency at 29.2%

Free Cash FlowQuality
$1.09B8/10

Generating 1.1B in free cash flow

Areas to Watch

CHYM4 concerns · Avg: 2.3/10
Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Return on EquityProfitability
-85.5%2/10

ROE of -85.5% — below average capital efficiency

EPS GrowthGrowth
-20.4%2/10

Earnings declined 20.4%

Altman Z-ScoreHealth
-1.152/10

Distress zone — elevated risk

SAP2 concerns · Avg: 4.0/10
P/E RatioValuation
26.3x4/10

Moderate valuation

Revenue GrowthGrowth
3.3%4/10

3.3% revenue growth

Comparative Analysis Report

WallStSmart Research

Bull Case : CHYM

The strongest argument for CHYM centers on Debt/Equity, Revenue Growth. Revenue growth of 25.5% demonstrates continued momentum.

Bull Case : SAP

The strongest argument for SAP centers on Market Cap, Altman Z-Score, Debt/Equity. Profitability is solid with margins at 19.5% and operating margin at 29.2%. PEG of 0.79 suggests the stock is reasonably priced for its growth.

Bear Case : CHYM

The primary concerns for CHYM are Piotroski F-Score, Return on Equity, EPS Growth.

Bear Case : SAP

The primary concerns for SAP are P/E Ratio, Revenue Growth.

Key Dynamics to Monitor

CHYM profiles as a growth stock while SAP is a value play — different risk/reward profiles.

CHYM is growing revenue faster at 25.5% — sustainability is the question.

SAP generates stronger free cash flow (1.1B), providing more financial flexibility.

Monitor SOFTWARE - APPLICATION industry trends, competitive dynamics, and regulatory changes.

Bottom Line

SAP scores higher overall (58/100 vs 35/100), backed by strong 19.5% margins. Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Chime Financial, Inc. Class A Common Stock

TECHNOLOGY · SOFTWARE - APPLICATION · USA

Chime Financial, Inc., a financial technology company, provides digital consumer banking and payment solutions. The company is headquartered in San Francisco, California.

SAP SE ADR

TECHNOLOGY · SOFTWARE - APPLICATION · USA

SAP SE is a global enterprise application software company. The company is headquartered in Walldorf, Germany.

Visit Website →

Want to dig deeper into these stocks?